Search

everythinglearnresearchcommunity

for

Search:↓

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

Targeting specific T cells may help treat alopecia areata.

Auto-antibody testing is a useful but not definitive tool in diagnosing interstitial lung diseases, and using a specific algorithm could make testing more cost-effective.

A specific type of immune cell plays a key role in causing alopecia areata and could be a target for treatment.

Secukinumab reduces immune activity in hidradenitis suppurativa skin.

UV light helped human hair transplants survive in mice without broad immunosuppression.

Gene sequencing is crucial for diagnosing Junctional epidermolysis bullosa.

The drug showed promise in treating renal cell carcinoma with manageable side effects.

LHTric-1 is a specific antibody useful for studying hair and nail formation.

Silicate-based therapy may help treat inflammatory heart disease by reducing immune inflammation.

Ritlecitinib shows promise for hair regrowth in alopecia areata patients.

The research found a way to identify and study skin cells with stem cell traits, revealing they behave differently in culture and questioning current stemness assessment methods.

Blocking LFA-1 prevents hair loss in mice.

Vismodegib effectively treats advanced basal cell carcinoma but requires careful management of serious side effects.

Doxycycline can effectively treat hair loss caused by EGFR inhibitors.

Scientists found a new protein, AMY117, common in Alzheimer's patients, which could be important for treatment and diagnosis.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

Super-enhancers control CD25 expression in specific cell types, affecting immune function.

Topical immunotherapy, especially with DPCP, is effective for treating severe alopecia areata.

Blocking IL-12/IL-23p40 helped reverse severe hair loss in patients.

MPZL3 is crucial for seborrheic dermatitis development.

EGFRi/MEKi treatments cause hair follicles to lose some immune protection, leading to inflammation.

Pertussis toxin may contribute to hair loss in alopecia areata.

As of December 2021, the most effective COVID-19 treatments were monoclonal antibodies and possibly early-administered convalescent plasma, while several drugs were found ineffective or were still under evaluation.

Sintilimab with chemotherapy improves survival and response in advanced lung cancer but increases some side effects.

Baricitinib helped treat a man's beard hair loss when steroids didn't work.

GBP1 is a key target for treating Epstein-Barr virus-related kidney cancer, and finasteride may help.

Mechlorethamine treatment regrew hair in mice by killing immune cells causing hair loss without harming hair follicles.